Veterinary Pain Management Market Size, Share & Trends Analysis Report By Product (Drugs, NSAIDs, Anesthetics, Opioids, Other Drugs), Devices (Laser Therapy, Electromagnetic Therapy), By Application (Osteoarthritis and Joint Pain, Postoperative Pain, Cancer, Other Applications), By Animal Type (Companion, Livestock), By End User (Hospitals and Clinics, Retail Outlet and Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Veterinary Pain Management Market Size

The global veterinary pain management market size was valued at USD 1.78 billion in 2025 and is projected to grow from USD 1.88 billion in 2026 to USD 2.95 billion by 2034, registering a CAGR of 5.78% during the forecast period from 2026 to 2034. North America dominated the veterinary pain management market with a market share of 39.2% in 2025.

The rising burden of chronic and other inflammatory diseases is a growing primary concern in animal healthcare. Some of the frequent pain experienced by animals are osteoarthritis, joint pain, and pain caused due to cancer cases such as osteosarcoma. Many chronic diseases in animals often lead to surgical treatments accompanied by postoperative pain. This factor is also expected to create a healthy demand for pain management products. Moreover, it is anticipated that the market under study will benefit from the government's and other organizations' growing activities.

• For example, the World Small Animal Veterinary Association (WSAVA) launched a campaign in 2018 focused on managing pain in companion animals, in which advice will be given to veterinary experts by the newest and best methods of veterinary pain management.

Product Insights

The global market is segmented into drugs and devices. The drug segment is divided into NSAIDs, anesthetics, opioids, and other drugs. The devices segment is further divided into laser therapy and electromagnetic therapy. The drugs segment accounted for the largest market share and is estimated to grow at a CAGR of 6.6% during the forecast period. Within the drug segment, NSAIDs accounted for the largest market share and is estimated to grow at a CAGR of 6.8% during the forecast period. Approved veterinary NSAIDs are used in companion and farm animal medicine to treat dogs, horses, and other animals with osteoarthritis-related pain and inflammation. A few NSAIDs for animals have been authorized to treat postoperative pain in cats and dogs. Some well-established companies offering NSAIDS are Zoetis Inc., which provides Rimadyl, and Elanco Inc., which offers Grapiprant. Moreover, highly developed and well-established animal healthcare companies providing NSAIDs have fuelled the growth.

Depending on the application, the global veterinary pain management market is segmented into osteoarthritis and joint pain, postoperative pain, cancer, and other applications. The osteoarthritis and joint pain segment accounted for the largest market share and is estimated to grow at a CAGR of 6.6% during the forecast period. Osteoarthritis and joint pain is also correlated with the obese condition in animals. Studies have shown that most osteoarthritis animals are overweight.

• For example, according to American Animal Hospital Association 2020, obese dogs are 2.3 times more likely to be diagnosed with osteoarthritis, while dogs with osteoarthritis are 1.7 times more likely to be overweight. Moreover, according to Banfield Pet Hospital Report, 2019, one out of three dogs and cats in the United States is overweight.

Thus, the diseases associated with weight, such as osteoarthritis and joint pain, have also been on the rise. In addition to the same source, 52% of dogs and 41% of cats with osteoarthritis are overweight in the United States. Over the past ten years, there has been a 66% increase in dogs' osteoarthritis and a 150% increase in cats' osteoarthritis. Thus, it is evident that the prevalence of osteoarthritis is increasing with the growing obese population, thus, triggering overall market growth.

Request Customizationto receive a tailored report.

Animal Type Insights

The global market is segmented into companion and livestock. The companion segment accounted for the largest market share and is estimated to grow at a CAGR of 6.8% during the forecast period. Companion animals provide companionship to human beings. Some companion animals include dogs, cats, birds, and horses. The rising pain conditions among companion animals and increasing companion animal ownership drive market growth. Osteoarthritis is a severe condition observed in most companion animals. As per Banfield's report 2019, the prevalence of osteoarthritis in dogs was higher in the United States. Thus, the increasing prevalence of pain disorders leads to the demand for diagnosis and increasing market growth.

End-User Insights

The global market is segmented into hospitals and clinics, retail outlets, and others. The hospitals and clinics segment dominated the market and is estimated to grow at a CAGR of 6.6% during the forecast period. Hospitals and clinics consume most drugs and devices associated with pain management. Licensed veterinary professionals must administer many drugs (anesthetics) and devices. The presence of skilled veterinarians is also a key factor influencing this segment. Many studies have found that veterinarians are highly aware of the pain experienced by animals and the need to manage it.

• For instance, as per the study reported in the International Journal of Veterinary Science and Medicine, 2019, pain assessment in animals of different species gained importance among veterinary hospitals and clinics. Hence, the rising importance of pain management among veterinarians is expected to augment the demand for products.

According to the Federal Trade Commission data, several pet medication manufacturers that include pain-related products prefer distributing products through veterinary practices. Traditionally, veterinarians have been the primary source of providing medicines to consumers. Therefore, the presence of skilled professionals and the increasing importance of assessing pain among them are expected to fuel market growth.

Speak to an Analystto discuss market opportunities.

Regional Insights

North America accounted for the largest market share and is estimated to grow at a CAGR of 6.8% during the forecast period. Due to factors like expanding pet adoption and rising per capita spending on veterinary care, the United States is anticipated to maintain its sizeable market share. The primary driver of the market's expansion has also been highlighted as the increase in numerous animal ailments and injuries. The number of people who keep pets and livestock and their views toward these animals' health have increased. The American Pet Products Association Americans reported that they are spending more money on pets, which could spur industry growth. According to data from the American Veterinary Medical Association, the US spent around USD 29.3 billion on veterinary services and care in March 2020. Therefore, the market is anticipated to have significant expansion due to the rising awareness of and spending on animal health.

Unlock Regional Insightsto access country-level data, & regional trends.

Europe Veterinary Pain Management Market Trends

Europe is the second largest region and is estimated to reach an expected value of USD 680 million by 2030 at a CAGR of 6.2%. The growth of the German market can be attributed to the rising population of livestock animals and growing pet adoption, with the introduction of new products. Furthermore, according to Destatis, as of November 2020, there were about 20,500 farms in Germany. Most sheep live in Bavaria, with 250,600 animals, followed by Baden-Württemberg, with 207,600, and Schleswig-Holstein, with 190,000 animals. Thus, the high numbers of livestock are expected to impact the market positively. Boehringer Ingelheim, Germany's animal health division, is also found to generate new solutions, research, and develop specific technologies for pain therapies in pets. Thus, this type of research activities, innovation, and new advanced solutions for veterinary care may propel market growth. Hence, these factors propel the market growth over the forecast period.

Asia Pacific Market Trends

The Asia Pacific is the third largest region. The Chinese veterinary pain management market has grown rapidly over the past few years and is undergoing several transformations. Over recent years, China witnessed a significant increase in the adoption of pet dogs and cats, as they are the most favored companions of human beings. Moreover, movements toward animal welfare and animal rights have been expanding in China, which is expected to augment market growth. In 2019, the World Small Animal Veterinary Association (WSAVA) collaborated with ACTAsia, a non-profit organization that provides veterinary training in China, to promote animal welfare. The collaboration supports the development of veterinary-related professions in China. Therefore, increasing the number of animals and raising awareness about animal health to contribute to the growing demand for diversified forms of companion animal pain management products.

List of Key and Emerging Players in Veterinary Pain Management Market